DCM
EPIX

DAFNA Capital Management’s ESSA Pharma EPIX Stock Holding History

DAFNA Capital Management’s Portfolio EPIX Stock Details EPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-4,902
Closed -$289K – 75
2016
Q4 		$289K Sell
4,902
-4,873
-50% -$212K 0.25% 58
2016
Q3 		$733K Sell
9,775
-350
-3% -$18.7K 0.51% 48
2016
Q2 		$810K Hold
10,125
– – 0.64% 47
2016
Q1 		$662K Sell
10,125
-1,300
-11% -$84.8K 0.57% 50
2015
Q4 		$1.04M Hold
11,425
– – 0.93% 30
2015
Q3 		$1.42M Buy
+11,425
New +$1.59M 1.41% 20

Other funds holding EPIX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $141M AUM 783.79% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $528B AUM 27.57% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $245B AUM 31.4% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return